C. Roland Wolf

Active 1977–2024

Also published as
C.Roland Wolf
141
Papers
22,811
Citations
90
h-index
140
i10-index

Citations

Citations per year for C. Roland Wolf1977: 2 citations1978: 1 citations1979: 1 citations1980: 4 citations1981: 5 citations1982: 5 citations1983: 6 citations1984: 15 citations1985: 15 citations1986: 19 citations1987: 9 citations1988: 33 citations1989: 25 citations1990: 54 citations1991: 49 citations1992: 76 citations1993: 80 citations1994: 92 citations1995: 116 citations1996: 109 citations1997: 159 citations1998: 155 citations1999: 177 citations2000: 209 citations2001: 238 citations2002: 222 citations2003: 266 citations2004: 268 citations2005: 270 citations2006: 220 citations2007: 230 citations2008: 226 citations2009: 242 citations2010: 225 citations2011: 195 citations2012: 157 citations2013: 149 citations2014: 137 citations2015: 120 citations2016: 115 citations2017: 100 citations2018: 119 citations2019: 392 citations2020: 373 citations2021: 339 citations2022: 274 citations2023: 211 citations2024: 268 citations2025: 142 citations2026: 4 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,252 citing papers, 28.8% of this breakdownUnited Kingdom: 917 citing papers, 11.7% of this breakdownChina: 640 citing papers, 8.2% of this breakdownGermany: 447 citing papers, 5.7% of this breakdownJapan: 347 citing papers, 4.4% of this breakdownFrance: 239 citing papers, 3% of this breakdownItaly: 236 citing papers, 3% of this breakdownCanada: 225 citing papers, 2.9% of this breakdownAustralia: 186 citing papers, 2.4% of this breakdownNetherlands: 185 citing papers, 2.4% of this breakdownSweden: 182 citing papers, 2.3% of this breakdownSouth Korea: 147 citing papers, 1.9% of this breakdown
0%28.8%Other 23.3%

Fields

  • Biochemistry, Genetics and Molecular Biology44%
  • Medicine24.6%
  • Pharmacology, Toxicology and Pharmaceutics18.6%
  • Environmental Science2.4%
  • Agricultural and Biological Sciences2%
  • Neuroscience1.9%
  • Other6.5%

Topics

  • Pharmacogenetics and Drug Metabolism8.3%
  • Genomics, phytochemicals, and oxidative stress7.1%
  • Glutathione Transferases and Polymorphisms6.3%
  • Drug Transport and Resistance Mechanisms4.6%
  • Computational Drug Discovery Methods2%
  • Epigenetics and DNA Methylation1.8%
  • Other69.9%

Coauthors

All papers

Open in search
  1. Feedback control of AHR signalling regulates intestinal immunity

    Authors: , , , , , , , , , , - Nature 2017 cited by 542

  2. Cyp2c70 is responsible for the species difference in bile acid metabolism between mice and humans

    Authors: , , , , , , , , - Journal of Lipid Research 2016 cited by 306

  3. Identification of retinoic acid as an inhibitor of transcription factor Nrf2 through activation of retinoic acid receptor alpha

    Authors: , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2007 cited by 303

  4. Loss of the Nrf2 transcription factor causes a marked reduction in constitutive and inducible expression of the glutathione S-transferase Gsta1, Gsta2, Gstm1, Gstm2, Gstm3 and Gstm4 genes in the livers of male and female mice

    Authors: , , , , , , , , , , , - Biochemical Journal 2002 cited by 448

  5. Regulation of JNK signaling by GSTp

    Authors: , , , , , , , , , , , - The EMBO Journal 1999 cited by 1,122

  6. The Cap'n'Collar basic leucine zipper transcription factor Nrf2 (NF-E2 p45-related factor 2) controls both constitutive and inducible expression of intestinal detoxification and glutathione biosynthetic enzymes.

    Authors: , , , , , , , , - 2001 cited by 656

  7. Tauroursodeoxycholic Acid Prevents MPTP-Induced Dopaminergic Cell Death in a Mouse Model of Parkinson’s Disease

    Authors: , , , , , , - Molecular Neurobiology 2012 cited by 156

  8. Generation of a Stable Antioxidant Response Element–Driven Reporter Gene Cell Line and Its Use to Show Redox-Dependent Activation of Nrf2 by Cancer Chemotherapeutic Agents

    Authors: , , - Cancer Research 2006 cited by 312

  9. Generation Scotland: the Scottish Family Health Study; a new resource for researching genes and heritability

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - BMC Medical Genetics 2006 cited by 312

  10. Through a glass, darkly? HepaRG and HepG2 cells as models of human phase I drug metabolism

    Authors: , - Drug Metabolism Reviews 2022 cited by 56

  11. Mutations in APC, Kirsten-ras, and p53—alternative genetic pathways to colorectal cancer

    Authors: , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2002 cited by 522

  12. Efficient Differentiation of Hepatocytes from Human Embryonic Stem Cells Exhibiting Markers Recapitulating Liver Development In Vivo

    Authors: , , , , , , , , , , - Stem Cells 2008 cited by 439

  13. Aryl hydrocarbon receptor is required for optimal B‐cell proliferation

    Authors: , , , , , , , - The EMBO Journal 2016 cited by 90

  14. Glutathione-S-transferase P promotes glycolysis in asthma in association with oxidation of pyruvate kinase M2

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Redox Biology 2021 cited by 43

  15. A General Strategy for the Expression of Recombinant Human Cytochrome P450s inEscherichia coliUsing Bacterial Signal Peptides: Expression of CYP3A4, CYP2A6, and CYP2E1

    Authors: , , , , , , - Archives of Biochemistry and Biophysics 1997 cited by 127

  16. Glutathione S-transferase P1 (GSTP1) directly influences platinum drug chemosensitivity in ovarian tumour cell lines

    Authors: , , , , , , - British Journal of Cancer 2014 cited by 126

  17. Defining the Contribution of CYP1A1 and CYP1A2 to Drug Metabolism Using Humanized CYP1A1/1A2 and Cyp1a1/Cyp1a2 Knockout Mice

    Authors: , , , , - Drug Metabolism and Disposition 2019 cited by 60

  18. Unsaturated fatty acid regulation of cytochrome P450 expression via a CAR-dependent pathway

    Authors: , , , - Biochemical Journal 2008 cited by 89

  19. The Nrf2 transcription factor contributes both to the basal expression of glutathione S-transferases in mouse liver and to their induction by the chemopreventive synthetic antioxidants, butylated hydroxyanisole and ethoxyquin

    Authors: , , , , , , , - Biochemical Society Transactions 2000 cited by 318

  20. The Peroxisome Proliferator-activated Receptor δ Promotes Lipid Accumulation in Human Macrophages

    Authors: , , , , , , , , , , - Journal of Biological Chemistry 2001 cited by 266

  21. NADPH–Cytochrome P450 Oxidoreductase: Roles in Physiology, Pharmacology, and Toxicology

    Authors: , , , , , , , , , , , , - Drug Metabolism and Disposition 2012 cited by 145

  22. Nomenclature for human glutathione transferases

    Authors: , , , , , , , , , , , , , - Biochemical Journal 1992 cited by 676

  23. Evidence for involvement of multiple forms of cytochrome P-450 in aflatoxin B1 metabolism in human liver.

    Authors: , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 1990 cited by 197

  24. Endogenous drug transporters in in vitro and in vivo models for the prediction of drug disposition in man

    Authors: , , , , , , - Biochemical Pharmacology 2002 cited by 156